STAT6 gain-of-function variant exacerbates multiple allergic symptoms

被引:34
|
作者
Takeuchi, Ichiro [1 ,2 ]
Yanagi, Kumiko [3 ]
Takada, Shuji [4 ]
Uchiyama, Toru [5 ]
Igarashi, Arisa [3 ,6 ]
Motomura, Kenichiro [6 ]
Hayashi, Yuka [6 ]
Nagano, Naoko [6 ]
Matsuoka, Ryo [6 ]
Sugiyama, Hiroki [6 ]
Yoshioka, Takako [7 ]
Saito, Hirohisa [6 ]
Kawai, Toshinao [4 ,5 ]
Miyaji, Yumiko [4 ,8 ]
Inuzuka, Yusuke [4 ,8 ]
Matsubara, Yoichi [4 ,9 ]
Ohya, Yukihiro [4 ,8 ]
Shimizu, Toshiaki [2 ,4 ]
Matsumoto, Kenji [4 ,6 ]
Arai, Katsuhiro [1 ,4 ,8 ,12 ]
Nomura, Ichiro [4 ,8 ,10 ,11 ]
Kaname, Tadashi [3 ,4 ,11 ]
Morita, Hideaki [4 ,6 ,8 ,11 ]
机构
[1] Juntendo Univ, Grad Sch Med, Ctr Pediat Inflammatory Bowel Dis, Natl Ctr Child Hlth & Dev,Div Gastroenterol, Tokyo, Japan
[2] Juntendo Univ, Grad Sch Med, Dept Pediat & Adolescent Med, Tokyo, Japan
[3] Natl Res Inst Child Hlth & Dev, Dept Genome Med, Tokyo, Japan
[4] Natl Res Inst Child Hlth & Dev, Dept Syst Biomed, Tokyo, Japan
[5] Natl Ctr Child Hlth & Dev, Div Immunol, Tokyo, Japan
[6] Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo, Japan
[7] Natl Ctr Child Hlth & Dev, Dept Pathol, Tokyo, Japan
[8] Natl Ctr Child Hlth & Dev, Allergy Ctr, Tokyo, Japan
[9] Natl Res Inst Child Hlth & Dev, Tokyo, Japan
[10] Natl Res Inst Child Hlth & Dev, Div Eosinophil Gastrointestinal Disorders, Tokyo, Japan
[11] Natl Res Inst Child Hlth & Dev, Okura 2-10-1 Setagaya Ward, Tokyo 1578535, Japan
[12] Natl Ctr Child Hlth & Dev, Ctr Pediat Inflammatory Bowel Dis, Div Gastroenterol, Okura 2-10-1 Setagaya Ward, Tokyo 1578535, Japan
关键词
STAT6; hyper-IgE syndrome; hypereosinophilia; pri-mary atopic disorders; atopic dermatitis; eosinophilic gastrointes-tinal disorder; ATOPIC-DERMATITIS; INBORN-ERRORS; IMMUNITY;
D O I
10.1016/j.jaci.2022.12.802
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Allergic diseases were long considered to be complex multifactorial disorders. However, recent findings indicate that severe allergic inflammation can be caused by monogenic immune defects. Objectives: We sought to clarify the molecular pathogenesis of a patient with early-onset multiple allergic diseases, a high serum IgE level, hypereosinophilia, treatment-resistant severe atopic dermatitis with increased dermal collagen fiber deposition, and eosinophilic gastrointestinal disorder with numerous polypoid nodules. Methods: A missense variant in STAT6 was identified, and its function was examined using peripheral blood, transfected HEK293 cells, lymphoblastoid cell lines, and knock-in mice with the corresponding mutation. Results: Whole-exome sequencing identified a de novo heterozygous missense variant in signal transducer and activator of transcription 6 (STAT6) (p.Asp419Asn). Luciferase reporter assay revealed that the transcriptional activity of this STAT6 mutant was upregulated even without IL-4 stimulation. Phosphorylation of STAT6 was not observed in either the patient's TH2 cells or lymphoblastoid cell lines without stimulation, whereas it was induced more strongly in both by IL-4 stimulation compared with healthy controls. STAT6 protein was present in the nuclear fraction of the lymphoblastoid cell lines of the patient even in the absence of IL-4 stimulation. The patient's gastric mucosa showed upregulation of STAT6-, fibrosis-, and germinal center formation-related molecules. Some of the knock-in mice with the corresponding mutation spontaneously developed dermatitis with skin thickening and eosinophil infiltration. Moreover, serum IgE levels and mRNA expression of type 2 cytokines were increased in the knock-in mice-with or without development of spontaneous dermatitis-compared with the wild-type mice. Conclusions: A novel STAT6 gain-of-function variant is a potential cause of primary atopic disorders. (J Allergy Clin Immunol 2023;151:1402-9.)
引用
收藏
页码:1402 / +
页数:14
相关论文
共 50 条
  • [21] STAT3 gain-of-function syndrome
    Vogel, Tiphanie P.
    Leiding, Jennifer W.
    Cooper, Megan A.
    Satter, Lisa Forbes R.
    FRONTIERS IN PEDIATRICS, 2023, 10
  • [22] STAT6: an intracellular target for the inhibition of allergic disease
    Foster, PS
    CLINICAL AND EXPERIMENTAL ALLERGY, 1999, 29 (01): : 12 - 16
  • [23] Interleukin 4 regulates phosphorylation of serine 756 in the transactivation domain of Stat6 - Roles for multiple phosphorylation sites and Stat6 function
    Wang, YL
    Malabarba, MG
    Nagy, ZS
    Kirken, RA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (24) : 25196 - 25203
  • [24] Complex role of STAT6 in allergic airway inflammation
    Chapoval, Svetlana P.
    Kelly-Welch, Ann E.
    Smith, Elizabeth
    Keegan, Achsah D.
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [25] Autosomal Dominant STAT6 Gain of Function Causes Severe Atopy Associated with Lymphoma
    Ekaterina Minskaia
    Jesmeen Maimaris
    Persephone Jenkins
    Adriana S. Albuquerque
    Ying Hong
    Despina Eleftheriou
    Kimberly C. Gilmour
    Richard Grace
    Fernando Moreira
    Bodo Grimbacher
    Emma C. Morris
    Siobhan O. Burns
    Journal of Clinical Immunology, 2023, 43 : 1611 - 1622
  • [26] Autosomal Dominant STAT6 Gain of Function Causes Severe Atopy Associated with Lymphoma
    Minskaia, Ekaterina
    Maimaris, Jesmeen
    Jenkins, Persephone
    Albuquerque, Adriana
    Hong, Ying
    Eleftheriou, Despina
    Gilmour, Kimberly
    Grace, Richard C.
    Moreira, Fernando O.
    Grimbacher, Bodo
    Morris, Emma C.
    Burns, Siobhan O.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (07) : 1611 - 1622
  • [27] STAT1 gain-of-function and chronic demodicosis
    Molho-Pessach, Vered
    Meltser, Arnon
    Kamshov, Adaia
    Ramot, Yuval
    Zlotogorski, Abraham
    PEDIATRIC DERMATOLOGY, 2020, 37 (01) : 153 - 155
  • [28] Is Gain-of-function STAT1 CMC An Interferonopathy?
    Al Shehri, Tariq
    Abinun, Mario
    Gennery, Andrew R.
    Rice, Gillian I.
    Crow, Yanik J.
    Lilic, Desa
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 182 : 15 - 15
  • [29] Janus kinase inhibitors ameliorate clinical symptoms in patients with STAT3 gain-of-function
    Kaneko, Shuya
    Sakura, Fumiaki
    Tanita, Kay
    Shimbo, Asami
    Nambu, Ryusuke
    Yoshida, Masashi
    Umetsu, Shuichiro
    Inui, Ayano
    Okada, Chizuru
    Tsumura, Miyuki
    Yamada, Mamiko
    Suzuki, Hisato
    Kosaki, Kenjiro
    Ohara, Osamu
    Shimizu, Masaki
    Morio, Tomohiro
    Okada, Satoshi
    Kanegane, Hirokazu
    IMMUNOTHERAPY ADVANCES, 2023, 3 (01):
  • [30] Novel STAT1 gain-of-function variant in a patient with Bechet's like clinical phenotype
    Aluri, Jahnavi
    Schmitt, Erica
    Kolicheski, Ana
    Du, Matthew
    Saucier, Nermina
    Cooper, Megan
    CLINICAL IMMUNOLOGY, 2023, 250 : 1 - 2